Prognostic Value of Il-6 and Il-8 for Risk Stratification in Community-Acquired Pneumonia in Children

Key Points

• The aim is to evaluate the prognostic value of IL-6 and IL-8 in community-acquired pneumonia in children.
• Analysis of IL-6 and IL-8 levels in children diagnosed with community-acquired pneumonia.
• Comparison of biomarker levels to clinical outcomes.
• Risk stratification based on cytokine levels.
• Higher levels of IL-6 and IL-8 correlate with increased severity of pneumonia.
• These biomarkers can help identify children at greater risk for complications.
• IL-6 and IL-8 are valuable for clinical decision-making regarding treatment.